Pheochromocytoma is a rare tumor of the adrenal gland that makes extra stress hormones. People with pheochromocytoma often have episodes of pounding headaches, sweating, palpitations, and very high blood pressure. It can occur at any age but is most often found in adults, and some cases run in families. The main treatment is surgical removal, and medicines to control blood pressure are used before and sometimes after surgery. Most people do well when treated, but untreated pheochromocytoma can be dangerous because of severe blood pressure spikes.
Overview
PheochromocytomaSymptoms
Pheochromocytoma can cause sudden spells of pounding headache, heavy sweating, and a racing, irregular heartbeat. Blood pressure often surges, bringing tremor, paleness, anxiety, and nausea. Early symptoms of pheochromocytoma may be brief and triggered by stress, exercise, or certain medicines.
Outlook and prognosis
Many people with Pheochromocytoma do well when the tumor is found early and removed, with blood pressure and symptoms often improving quickly. Lifelong follow-up is important because tumors can return or occur on both adrenal glands. Prognosis depends on tumor size, spread, and any inherited risks.
Causes and risk factors
Pheochromocytoma usually stems from gene changes; about one‑third are inherited, the rest arise spontaneously. Risks include a family history and syndromes like MEN2, VHL, NF1, or SDHx; it most often appears between ages 20–60. No proven lifestyle or environmental causes.
Genetic influences
Genetics play a major role in Pheochromocytoma. Up to half of cases link to inherited variants (e.g., RET, VHL, NF1, SDHx), often at younger ages or with multiple tumors. Genetic testing and counseling guide screening for patients and relatives.
Diagnosis
Doctors check plasma or 24-hour urine metanephrines to confirm catecholamine excess. Imaging with CT or MRI, sometimes MIBG or PET, then locates tumors. Genetic testing is often recommended as part of the diagnosis of pheochromocytoma.
Treatment and drugs
Treatment for pheochromocytoma focuses on safely controlling hormones and blood pressure, then removing the tumor. Doctors often start alpha-blockers (sometimes beta-blockers) and salt/fluids before surgery. If surgery isn’t possible or cancer has spread, targeted medicines, radiation, or ablation may help.
Symptoms
Pheochromocytoma often triggers sudden bursts of fight-or-flight hormones, leading to episodes of pounding heart, heavy sweating, and severe headaches, usually with high blood pressure. These episodes can last minutes to hours and may be set off by stress, exercise, bending, or even going to the toilet. Symptoms vary from person to person and can change over time. Early symptoms of pheochromocytoma are easy to mistake for anxiety, migraines, or menopause, so keeping track of when they happen and what you were doing can be helpful.
Blood pressure can spike suddenly or stay high between episodes. With pheochromocytoma, readings may swing from normal to very high over a short time. Some notice throbbing headaches or chest pressure when it surges.
Severe, throbbing pain often strikes during a hormone surge. It can build quickly and may come with light or sound sensitivity. The headache often eases as the episode passes.
The heart may race, pound, or feel like it is skipping beats. This can be frightening and may be felt in the neck or chest. In pheochromocytoma, the sensation often starts and stops abruptly.
Sudden, drenching sweat can soak clothing even in a cool room. You might notice it most with headaches or a racing pulse. Episodes often end as quickly as they begin.
How people usually first notice Pheochromocytoma?
People often first notice pheochromocytoma when sudden “spells” strike: pounding headaches, a racing or irregular heartbeat, sweating, tremor, pallor or flushing, and anxiety, sometimes with nausea or belly pain. These episodes can come in bursts lasting minutes to hours, often alongside very high blood pressure that may be constant or spike during stress, exercise, surgery, or even after certain foods or decongestants. For many, the first signs of pheochromocytoma are these unpredictable surges—especially severe or treatment‑resistant hypertension—prompting doctors to check blood or urine for excess adrenaline‑like hormones and order imaging to locate the tumor.
Types of Pheochromocytoma
People with pheochromocytoma can experience it in a few distinct ways, which affect day-to-day symptoms and long-term health planning. Clinicians often describe them in these categories: by whether the tumor makes hormones continuously or in bursts, whether it’s linked to an inherited syndrome, and whether it’s confined to the adrenal gland or has spread. Symptoms don’t always look the same for everyone. Understanding the main types of pheochromocytoma can help you and your care team anticipate patterns such as steady high blood pressure versus sudden spikes.
Adrenal pheochromocytoma
This is the most common type and starts in one or both adrenal glands. It typically releases adrenaline-like hormones that raise blood pressure, cause pounding headaches, and trigger sweating and palpitations.
Hereditary syndromic
Some pheochromocytomas occur as part of inherited conditions like MEN2, VHL, or NF1. These tend to appear at younger ages, may affect both adrenal glands, and increase the chance of more than one tumor over time.
Nonhereditary (sporadic)
These occur without a known inherited cause and usually present in mid-to-later adulthood. They are more often a single tumor in one adrenal gland, with symptoms that can be steady or come in sudden episodes.
Paraganglioma related
When similar tumors arise outside the adrenal gland, they are called paragangliomas. They can cause the same adrenaline surges or, if non-secreting, mainly lead to symptoms from pressure on nearby structures.
Secreting (functional)
These tumors actively release catecholamines, leading to classic episodes of high blood pressure, tremor, palpitations, sweating, and headaches. Some people notice triggers like stress, certain medications, or surgery that provoke hormone bursts.
Non-secreting (nonfunctional)
These tumors make little to no hormone, so blood pressure may be normal and symptoms milder or absent. They are often found on imaging done for another reason or because of a mass effect, not because of adrenaline symptoms.
Unilateral vs bilateral
A tumor in one adrenal gland usually causes fewer long-term hormone issues after removal. Tumors in both glands are more common in hereditary types and may require careful hormone replacement after surgery.
Localized vs metastatic
Localized disease is confined to the adrenal gland and nearby tissue, while metastatic pheochromocytoma has spread to other sites such as bone, liver, or lungs. Metastatic cases may cause ongoing hormone symptoms and need long-term, multi-step treatment, and people often ask about types of pheochromocytoma when planning care.
What genetics can tell you about symptoms
Some pheochromocytomas are driven by inherited gene changes, and the symptoms can hint at which gene is involved. For example, VHL variants often cause milder, episodic high blood pressure, while RET or NF1 variants more often bring persistent hypertension, palpitations, sweating, and headaches.
Causes and risk factors
Pheochromocytoma often begins when a gene change allows an adrenal tumor to form and release too much stress hormone.
About one third of cases are inherited, and others come from new gene changes with no family history.
Risk is higher when these tumors or related syndromes run in your family, so ask about screening and the early symptoms of pheochromocytoma.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental risks are unclear, and there are no proven lifestyle causes.
Environmental and biological risk factors
Pheochromocytoma is a rare adrenal tumor that can cause pounding headaches, a racing heartbeat, and sudden spikes in blood pressure. Early symptoms of pheochromocytoma may appear during ordinary routines, not only in moments of extreme stress. Doctors often group risks into internal (biological) and external (environmental). For this condition, most risk seems to come from biology inside the adrenal gland, and clear environmental triggers are uncommon.
Pheochromocytoma most often appears between ages 30 and 50. It can occur at any age, including in children and older adults, but that is less common.
No specific environmental chemicals or pollutants are proven to increase the risk of pheochromocytoma. Most people diagnosed have no identifiable outside exposure.
Genetic risk factors
Knowing the genetic side of pheochromocytoma can guide family screening and the timing of checks. About a third of cases are linked to inherited changes, so understanding genetic risk factors for pheochromocytoma helps families plan ahead. Carrying a genetic change doesn’t guarantee the condition will appear. Specific genes and syndromes raise risk in different ways, and patterns can vary between families.
Family history: Having a parent, brother, or sister with a known gene variant raises your chance. These variants usually pass in a dominant way, meaning each child has a 50% chance to inherit it. Exploring your family’s health background is a valuable starting point.
MEN2 (RET): This inherited syndrome often leads to adrenal tumors on one or both sides, including pheochromocytoma. It also carries a high risk of medullary thyroid cancer, so families with MEN2 are typically offered early, regular checks. Testing for the RET gene can confirm who is at risk.
VHL syndrome: Changes in the VHL gene raise the chance of adrenal tumors and paragangliomas, sometimes in both adrenal glands. People with VHL may also develop tumors in the eyes, brain, spine, pancreas, or kidneys. Lifelong surveillance helps catch adrenal tumors early.
Neurofibromatosis type 1: NF1 increases the risk of adrenal hormone‑producing tumors compared with the general population. Many living with NF1 notice skin findings and nerve-related tumors, and a smaller share develop adrenal gland overactivity. Risk tends to rise in adulthood.
SDHx genes: Variants in SDHB, SDHD, SDHC, SDHA, or SDHAF2 can cause pheochromocytoma or paraganglioma. SDHB is linked with a higher chance that tumors spread beyond their original site, while SDHD often shows risk mainly when inherited from the father. Families usually benefit from early, periodic checks.
MAX gene: Changes in this gene often lead to adrenal tumors, sometimes on both sides. Relatives may share the same risk, so targeted testing can clarify who needs monitoring.
TMEM127 gene: This gene is associated with adrenal tumors, usually appearing in adulthood. The chance of spread is generally lower than with SDHB, but regular follow‑up is still important.
Other rare genes: Less commonly, changes in FH, EPAS1 (also called HIF2A), EGLN1 (PHD2), or KIF1B raise risk for pheochromocytoma or paraganglioma. Some have distinctive patterns, such as early onset or high red blood cell counts, which can guide testing.
New gene changes: Sometimes a genetic change arises for the first time in someone with pheochromocytoma, so there may be no family history. In some cases, genetic testing can give a clearer picture of your personal risk.
Lifestyle risk factors
Lifestyle does not cause Pheochromocytoma, but daily habits can trigger catecholamine surges, intensify blood pressure spikes, and complicate symptom control. Understanding how lifestyle affects Pheochromocytoma can help reduce dangerous episodes between diagnosis and treatment. The points below focus on behaviors that may amplify symptoms or make them harder to manage.
Coffee, strong tea, and energy drinks can stimulate the sympathetic nervous system and raise blood pressure. They may trigger palpitations, headaches, and anxiety-like spells in people with Pheochromocytoma.
Alcohol can provoke blood pressure swings and arrhythmias, especially with larger amounts or binge drinking. Cutting back may reduce hypertensive episodes and post-drinking rebound symptoms.
Excess salt can elevate baseline blood pressure and intensify hypertensive crises. Unless specifically advised during preoperative preparation, moderating sodium may help stabilize readings.
Aged cheeses, cured meats, and fermented products may precipitate adrenergic symptoms in some people. Avoiding potential triggers can help limit sudden blood pressure spikes.
Risk prevention
Pheochromocytoma can’t always be prevented, especially when it runs in families, but you can lower risks by staying alert to triggers and by catching problems early. Prevention is about lowering risk, not eliminating it completely. For many, that means regular checks, medication reviews, and planning ahead for surgery or pregnancy. Recognizing early symptoms of pheochromocytoma—sudden pounding headaches, a racing heartbeat, heavy sweating, and spikes in blood pressure—can lead to quicker testing and safer care.
If pheochromocytoma runs in your family or you have a related syndrome, ask about genetic counseling and testing. Finding a gene change can guide screening for you and your relatives.
If you’re high-risk, schedule periodic blood or urine tests for adrenal hormone byproducts (metanephrines), and imaging if your care team recommends it. Catching a tumor early makes treatment safer and more effective.
Ask your doctor or pharmacist to check all medicines and supplements. Some decongestants, stimulants, and certain antidepressants can trigger dangerous blood pressure surges in people with pheochromocytoma.
Keep caffeine and nicotine modest, or avoid them if advised. Illicit stimulants like cocaine or amphetamines are especially risky and can provoke attacks.
Transmission
Pheochromocytoma isn’t contagious—you can’t catch it or pass it to others through contact. Many cases happen by chance with no family history, but roughly one-third are due to inherited gene changes. For the genetic transmission of pheochromocytoma, it usually means one altered copy of a gene from either parent is enough: if a parent carries the change, each child has a 50% chance to inherit it, though not everyone who inherits it will develop pheochromocytoma. New gene changes can also occur for the first time in someone, so a negative family history doesn’t rule out a genetic form.
When to test your genes
Consider genetic testing if you were diagnosed with pheochromocytoma at a young age, have multiple or bilateral tumors, recurrent disease, or a family history of pheochromocytoma, paraganglioma, or related endocrine tumors. Testing also matters if you have high blood pressure episodes with suggestive features and no clear cause. Results can guide screening for hidden tumors, tailor surgery, and inform relatives’ risk.
Diagnosis
Pheochromocytoma is usually picked up when repeated spikes in blood pressure, pounding headaches, or a racing heartbeat lead someone to seek care. These tumors release stress hormones (like adrenaline), so many notice sudden episodes of sweating, palpitations, or tremors that come and go. Doctors usually begin with a careful review of symptoms and focused tests, then move on to scans to find the tumor; this stepwise approach is the basis for the diagnosis of pheochromocytoma. Some have a family history, so genetic questions can be part of the visit.
Your clinician asks about headache, sweating, palpitations, panic-like episodes, and triggers such as exercise or stress. They check blood pressure sitting and standing and look for features linked to inherited syndromes. Patterns of brief, repeated “spells” help guide testing.
Readings may be very high during attacks and sometimes normal between them. Home or ambulatory monitors can capture swings missed in a single visit. Noting timing alongside symptoms can be informative.
A blood test measures breakdown products of adrenaline-like hormones. High levels strongly suggest a hormone-secreting tumor. Testing is ideally done at rest to reduce false positives.
A 24-hour urine collection measures the same hormone byproducts over a full day. This can help when symptoms are episodic. Results complement the blood test to improve accuracy.
Stages of Pheochromocytoma
Pheochromocytoma does not have defined progression stages. Its course varies—from silent tumors found on imaging to hormone surges that come and go—so care focuses on whether it makes excess adrenaline-like hormones and whether it has spread (metastatic disease), rather than on stepwise stages. Doctors usually confirm suspected cases by checking for elevated metanephrines in blood or 24-hour urine and then using imaging scans to find the tumor; early symptoms of pheochromocytoma may include sudden pounding headaches, sweating, a racing heartbeat, and spikes in blood pressure. Different tests may be suggested to help clarify the picture, and genetic testing may be offered when family history or age at diagnosis raises suspicion.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after hearing the word pheochromocytoma. The outlook is not the same for everyone, but most people do well when the tumor is found early and treated, usually with surgery. Before treatment, symptoms like pounding headaches, racing heart, and spikes in blood pressure can strain the heart, kidneys, and eyes; getting blood pressure under control before surgery lowers these risks. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. If the tumor is completely removed, blood pressure and other symptoms often improve within days to weeks, though some people need ongoing blood pressure medicines if vessels have stiffened over time.
Here’s what research and experience suggest about the future. About 10% to 20% of people have recurrence in the years after surgery, especially if the original tumor was large, there were multiple tumors, or a hereditary syndrome is present. Genetic testing can sometimes provide more insight into prognosis, because changes in certain genes are linked with higher chances of recurrence or spread. Metastatic pheochromocytoma (when cancer cells spread to places like bone, liver, or lungs) is less common but can be serious; survival varies widely, with many living for years with modern treatments and careful blood pressure control. Doctors call this the prognosis—a medical word for likely outcomes.
Looking at the long-term picture can be helpful. Regular follow-up is crucial: most guidelines suggest lifelong yearly checks of metanephrines and periodic imaging, since recurrence can appear even a decade later. Early symptoms of pheochromocytoma—such as new, sudden spikes in blood pressure, sweating episodes, or headaches—should prompt a call to your care team if they return after treatment. With ongoing care, many people maintain good quality of life, work, exercise, and carry on family plans. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Pheochromocytoma can have lasting effects on the heart, blood pressure, and metabolism, even after the tumor is removed. Many remember early symptoms of pheochromocytoma—pounding headaches, sweating, and a racing heartbeat—but the longer-term picture centers on risks like persistent hypertension and recurrence. Long-term effects vary widely, and depend on tumor type, whether it spread, and if a hereditary syndrome is involved.
High blood pressure can continue even after tumor removal due to changes in blood vessels and long-standing strain. This lingering effect is common in people treated for pheochromocytoma.
Surges of stress hormones can lead to a weakened heart muscle, rhythm problems, or heart failure. Some develop stress-induced cardiomyopathy that may improve, while others have lasting damage.
Spikes in adrenaline can cause insulin resistance and raise the chance of type 2 diabetes. For some, glucose levels remain hard to control after pheochromocytoma treatment.
Years of high blood pressure can damage kidney filters and slowly reduce kidney function. Over time this may lead to chronic kidney disease.
How is it to live with Pheochromocytoma?
Living with pheochromocytoma can feel unpredictable, with sudden surges of pounding headaches, palpitations, sweating, tremor, and anxiety-like spells that can interrupt work, sleep, or everyday errands. Because these tumors release excess stress hormones, blood pressure may spike without warning, so many build routines around monitoring, keeping medications handy, and knowing when to seek urgent care. For family and friends, it helps to understand that these episodes are medical, not “just stress,” and to support plans for calm spaces, flexible schedules, and rides to appointments. Most people find life steadier after treatment and follow-up, but ongoing checkups and awareness of recurrence keep the focus on long-term safety and peace of mind.
Treatment and drugs
Pheochromocytoma is treated by first stabilizing blood pressure and heart rate, then removing the tumor when it’s safe to do so. Doctors typically start with alpha-blocker medicines to relax blood vessels, then may add beta-blockers to control a fast heartbeat; a doctor may adjust your dose to balance benefits and side effects. Most people then have surgery to remove the tumor, sometimes using minimally invasive methods, with careful monitoring before, during, and after the operation to prevent dangerous blood pressure swings. If the tumor cannot be fully removed, or if it has spread, treatments can include targeted radiation, certain chemotherapy drugs, or newer targeted therapies, and hormone-blocking medicines to control symptoms. Alongside medical treatment, lifestyle choices play a role, such as staying well hydrated, avoiding triggers like excessive caffeine, and planning follow-up visits and genetic counseling when recommended.
Non-drug treatment
Living with pheochromocytoma can affect day-to-day routines because hormone surges can spike blood pressure and cause sudden symptoms. Alongside medicines, non-drug therapies can steady daily life, lower risk during procedures, and support long-term follow-up. These approaches focus on safe tumor removal, avoiding triggers, and learning practical self-care. Your care team will tailor choices to your age, health, and whether the tumor is inherited.
Surgery to remove the tumor is the main non-drug treatment and often provides lasting control of symptoms. A specialist team plans the safest approach, which may be minimally invasive when appropriate.
Under your team’s guidance, a higher-salt diet and good hydration can prepare your circulation for surgery. This can reduce dizziness when standing and help stabilize blood pressure.
Limit caffeine, nicotine, and over-the-counter decongestants that raise blood pressure. Avoid heavy lifting and straining, which can provoke hormone surges and worsening spells.
Gentle breathing, mindfulness, or guided relaxation can help blunt spikes in adrenaline-like hormones. Some strategies can slip naturally into your routine—like a 5-minute breathing break after stressful calls.
Your genes may have an impact on how drugs work for you
Medicines for pheochromocytoma can work differently based on genetic variants that affect tumor behavior and how your body processes drugs. Certain inherited mutations (like RET, VHL, or SDHx) may guide choice and dosing of alpha- and beta-blockers or targeted therapies.
Pharmacological treatments
Medicines for pheochromocytoma aim to calm the surge of stress hormones, steady blood pressure, and make surgery safer. They’re also used when surgery isn’t possible or if the tumor has spread. Early symptoms of pheochromocytoma like pounding headaches, sweating, or racing heartbeat may ease with the right drug plan, but tumor removal is usually the definitive treatment. Not everyone responds to the same medication in the same way.
Phenoxybenzamine or doxazosin relax blood vessels and are the foundation of treatment before surgery. They lower blood pressure and reduce spells of pounding heartbeat.
Propranolol or metoprolol control fast or irregular heartbeats but are added only after alpha-blockade is in place. Starting beta-blockers first can dangerously raise blood pressure.
Amlodipine or nicardipine help smooth out blood pressure if alpha-blockers aren’t enough or aren’t tolerated. They can be used alone or alongside alpha-blockers.
This drug (also called alpha-methyl-para-tyrosine) lowers hormone production at the source. It is often used with alpha-blockers before surgery or for hard‑to‑control symptoms.
Genetic influences
Genetics play a large role in pheochromocytoma, with about one-third to nearly half of cases linked to inherited gene changes. These include well-known family syndromes such as multiple endocrine neoplasia type 2, von Hippel–Lindau disease, and neurofibromatosis type 1, as well as changes in genes that affect how cells use energy. Having a gene change doesn’t always mean you will develop the condition. Inherited forms of pheochromocytoma often appear at a younger age, can involve both adrenal glands, or show up alongside related tumors called paragangliomas. Because the chance of a hereditary cause is relatively high, many experts recommend offering genetic testing for pheochromocytoma and counseling to everyone diagnosed. If a parent carries one of these gene changes, each child has a 50% chance of inheriting it, so finding the cause can guide screening and care for you and your family.
Is Pheochromocytoma genetic?
Genetics play a major role in Pheochromocytoma. Up to half of cases link to inherited variants (e.g., RET, VHL, NF1, SDHx), often at younger ages or with multiple tumors. Genetic testing and counseling guide screening for patients and relatives.
Pharmacogenetics—how genetics influence drug effects
For many, treatment planning depends partly on which gene change caused the tumor. Variants in RET or VHL raise the chance of tumors in both adrenal glands, so surgeons may consider adrenal-sparing approaches; SDHB is linked to a higher risk of spread, guiding closer follow-up and sometimes earlier use of systemic or nuclear medicine treatments. Tumor genetics also help predict which scans and targeted radiation are likely to work: changes in SDH genes often make tumors show on somatostatin receptor imaging and eligible for peptide receptor radionuclide therapy, while MIBG-based therapy is favored when the tumor takes up MIBG well. Because gene subtype influences how much adrenaline-like hormone the tumor makes, it can guide how strong preoperative alpha-blockade should be and how long to prepare before surgery. On the drug-metabolism side, differences in liver enzymes such as CYP2D6 can affect how you process beta-blockers like metoprolol or propranolol used after alpha-blockade, so doses may be adjusted to avoid side effects. A “slow metabolizer” may process medicine more slowly, so a standard dose could feel too strong; others may clear it faster and need a higher dose. Genetic results won’t change the early symptoms of pheochromocytoma, but they can personalize surgery, imaging, and medicine choices, and help your team plan lifelong screening for you and at-risk relatives.
Interactions with other conditions
When pheochromocytoma occurs alongside other conditions, the surges of stress hormones can complicate things like blood pressure and heart rhythm. Because early symptoms of pheochromocytoma—such as pounding headaches, sweating, and palpitations—overlap with anxiety, thyroid disease, or menopause, coexisting illnesses may delay recognition. High levels of these hormones can worsen existing hypertension, trigger irregular heartbeats or stress-related cardiomyopathy, and raise blood sugar, so diabetes and cardiovascular disease often need closer monitoring. Pheochromocytoma can also be part of inherited syndromes such as multiple endocrine neoplasia type 2, von Hippel–Lindau disease, and neurofibromatosis type 1, where it may occur with medullary thyroid cancer or overactive parathyroid glands. Shared genetic variants may explain why certain conditions cluster together. During pregnancy or before surgery for another condition, undiagnosed pheochromocytoma can pose serious risks, so coordinated care and careful medication choices are essential.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden spells of pounding heartbeat, sweating, and headaches that came and went without warning. A shopkeeper might feel perfectly fine all morning, then become flushed and shaky while wrapping a package, only to feel drained an hour later. Looking back, some of these stories likely reflect what we now recognize as pheochromocytoma.
First described in the medical literature as a rare adrenal growth in the late 19th century, pheochromocytoma was initially recognized at autopsy, when doctors noticed a dark, vascular mass on the adrenal gland. In the early 1900s, researchers linked these tumors to adrenaline-like chemicals that surge into the bloodstream, explaining the dramatic spikes in blood pressure and other symptoms. As blood pressure cuffs and lab tests became routine, clinicians began to recognize that certain “malignant hypertension” episodes were not just stress or anxiety, but biochemical storms set off by these tumors.
From early theories to modern research, the story of pheochromocytoma has been shaped by better tools. Mid-20th-century advances allowed measurement of catecholamines and their breakdown products in urine and blood, turning a once-hidden condition into a diagnosable one. Imaging progressed from plain X-rays to CT and MRI, and then to specialized nuclear scans that could “light up” these tumors. Together, these steps moved care from late discovery to earlier detection.
In recent decades, knowledge has built on a long tradition of observation. Families and communities once noticed patterns—relatives across generations with severe headaches and dangerous blood pressure swings. Genetics research later showed that a meaningful share of pheochromocytomas are linked to inherited changes, including those seen in multiple endocrine neoplasia type 2, von Hippel–Lindau syndrome, and mutations in genes that affect cellular oxygen sensing. This shifted screening from single individuals to entire families, so people at higher risk could be monitored before crises occurred.
Surgery has evolved as well. Early operations were high risk due to uncontrolled surges of blood pressure during anesthesia. With the introduction of careful preoperative medication to block adrenaline effects and improved surgical techniques, outcomes improved markedly. Minimally invasive procedures reduced recovery time, and modern critical care made dangerous swings in blood pressure more manageable.
Understanding has also broadened beyond the adrenal glands. Doctors learned that similar tumors, called paragangliomas, can arise along nerve pathways outside the adrenals, sometimes with different patterns of hormone release and risk. This refined how clinicians evaluate symptoms and choose imaging and follow-up.
Despite evolving definitions, the central theme has stayed the same: episodes that once seemed mysterious now have a clear biologic cause and a structured path to diagnosis and treatment. Today, people with suspected pheochromocytoma benefit from coordinated care—biochemical testing, focused imaging, genetic counseling when appropriate, and safer surgery—built on more than a century of careful observation and steady progress.